Market cap | $503.80B |
---|---|
Enterprise value | $517.81B |
Revenue | $379.487B |
---|---|
EBITDA | $36.202B |
Income | $15.361B |
Revenue Q/Q | 8.56% |
Revenue Y/Y | 12.96% |
P/E | 29.50 |
---|---|
Forward P/E | 17.06 |
EV/Sales | 1.36 |
EV/EBITDA | 14.30 |
EV/EBIT | 21.28 |
PEG | 1.66 |
Price/Sales | 1.33 |
P/FCF | 47.91 |
Price/Book | 5.68 |
Book/Share | 86.21 |
Cash/Share | 32.42 |
FCF yield | 2.09% |
Volume | 3.405M / 4.807M |
---|---|
Relative vol. | 0.71 × |
EPS | 16.59 |
---|---|
EPS Q/Q | 28.10% |
Est. EPS Q/Q | 15.18% |
Profit margin | 6.02% |
---|---|
Oper. margin | 8.49% |
Gross margin | 24.48% |
EBIT margin | 6.41% |
EBITDA margin | 9.54% |
Ret. on assets | 5.49% |
---|---|
Ret. on equity | 17.95% |
ROIC | 12.62% |
ROCE | 13.53% |
Debt/Equity | 1.97 |
---|---|
Net debt/EBITDA | 2.70 |
Current ratio | 0.85 |
Quick ratio | 0.85 |
Volatility | 2.04% |
---|---|
Beta | 0.06 |
RSI | 47.36 |
---|
Insider ownership | 0.47% |
---|---|
Inst. ownership | 90.12% |
Shares outst. | 920.385M |
---|---|
Shares float | 0.000 0.00% |
Short % of float | 0.49% |
Short ratio | 1.24 |
Dividend | $7.74 |
---|---|
Dividend yield | 1.58% |
Payout ratio | 46.65% |
Payment date | N/A |
Ex-dividend date | N/A |
Earnings date | 16 Jul 2024 |
Wednesday, 3 July 2024
|
|
The Dow Is Dipping. Blame UnitedHealth Stock. | |
Friday, 21 June 2024
|
|
The 30-stock secret: ‘Don’t fight Papa Dow’ | |
Thursday, 20 June 2024
|
|
UnitedHealth issues breach notification on Change Healthcare hack | |
Change Healthcare to start notifying customers who had data exposed in cyberattack | |
Monday, 17 June 2024
|
|
UnitedHealth Group Inc's Dividend Analysis | |
Friday, 14 June 2024
|
|
UnitedHealth Group Announces Earnings Release Date | |
Sunday, 9 June 2024
|
|
UnitedHealth Group's Dividend Will Be Increased To $2.10 | |
Friday, 7 June 2024
|
|
The Fastest-Declining State in the US | |
Wednesday, 5 June 2024
|
|
Community health centers still bogged down by red tape after UnitedHealth hack | |
Wednesday, 29 May 2024
|
|
UnitedHealth flags Medicaid-related 'disturbance,' stock down | |
US health insurer shares fall after UnitedHealth flags Medicaid enrollment issues | |
Market Chatter: Health Insurance Stocks Drop as UnitedHealth Flags 'Disturbance' in Medicaid | |
Friday, 24 May 2024
|
|
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February | |
Thursday, 23 May 2024
|
|
State of Kansas Selects UnitedHealthcare to Serve Medicaid and Children’s Health Insurance Program Beneficiaries | |
Sunday, 19 May 2024
|
|
Questor: This healthcare giant is struggling – making it a bargain buy | |
Thursday, 16 May 2024
|
|
New Survey Finds College Students Nearly 50% More Likely Than High Schoolers to Self-Report High-Risk Mental or Behavioral Health Concerns – and Parents May Not Know | |
Friday, 10 May 2024
|
|
A cyberattack on a big US health system diverts ambulances and takes records offline | |
Decoding UnitedHealth Group Inc : A Strategic SWOT Insight | |
Wednesday, 8 May 2024
|
|
Ascension warns of suspected cyberattack; clinical operations disrupted | |
Tuesday, 7 May 2024
|
|
13 Best Stocks That Will Always Grow | |
12 Best Investments for Beginners in 2024 | |
Monday, 6 May 2024
|
|
The Arc and United Health Foundation Launch $2.5M Partnership to Tackle Mental Health Crisis for People with Disabilities | |
Thursday, 2 May 2024
|
|
PRESS DIGEST- New York Times business news - May 2 | |
Wednesday, 1 May 2024
|
|
Change Healthcare cyberattack was due to a lack of multifactor authentication, UnitedHealth CEO says | |
UnitedHealth CEO Defends Cyberattack Response to Congress | |
Tuesday, 30 April 2024
|
|
Almost all US hospitals took financial hit from Change hack, AHA says | |
Monday, 29 April 2024
|
|
UnitedHealth hackers took advantage of Citrix vulnerabilty to break in, CEO says | |
Insider |
Trans.
Transaction
|
Total value |
---|---|---|
Stephen J Hemsley Director | Option 14 Jun 2024 | $57,534,677 |
Erin Mc Sweeney EVP and Chief People Officer | Sale 8 Mar 2024 | $597,581 |
Thomas E Roos Chief Accounting Officer | Sale 22 Feb 2024 | $451,128 |
Brian R Thompson CEO and UnitedHealthcare | Option 16 Feb 2024 | $21,016,857 |
Stephen J Hemsley Director | Option 5 Dec 2023 | $7,200,847 |
Stephen J Hemsley Director | Option 17 Oct 2023 | $9,990,963 |
Erin Mc Sweeney EVP and Chief People Officer | Option 16 Oct 2023 | $1,359,296 |
Andrew Witty CEO and UHG | Sale 19 Jul 2023 | $2,024,760 |
Andrew Witty CEO and UHG | Sale 27 Apr 2023 | $3,002,938 |
Erin Mc Sweeney EVP and Chief People Officer | Option 21 Apr 2023 | $1,813,200 |
Erin Mc Sweeney EVP and Chief People Officer | Option 19 Apr 2023 | $1,405,628 |
Powered by
Robintrack.
Price target
Current $489.34
Average $370.39
Low $315
High $409
Dividends
Ex-dividend date | N/A | Frequency | Quarterly | Annual dividend | +13.91% |
---|---|---|---|---|---|
Next dividend | N/A | Dividend yield | 1.58% | Growth period | 24 years |
Last dividend date | Yield 3 years | 1.39% | Growth 3 years | +14.71% | |
Last dividend | Yield 5 years | 1.33% | Growth 5 years | +16.14% |
Insider | Age | Since | Compensation |
---|---|---|---|
David Wichmann (57) Chief Executive Officer since 2017 | 57 | 2017 | $18,887,000 |
John Rex (58) Chief Financial Officer and Executive Vice President since 2016 | 58 | 2016 | $10,627,100 |
Dirk McMahon (60) Chief Executive Officer - UnitedHealthcare since 2019 | 60 | 2019 | $8,966,980 |
Stephen Hemsley (67) Non-Executive Chairman of the Board since 2019 | 67 | 2019 | $7,390,000 |
Marianne Short (69) Executive Vice President and Chief Legal Officer since 2013 | 69 | 2013 | $6,963,680 |
D. Ellen Wilson (61) Executive Vice President - Human Capital since 2013 | 61 | 2013 | $4,591,680 |
Patricia L. Lewis (59) Exec. VP and Chief HR Officer | 59 | $3,690,447 | |
Dirk C. McMahon (61) Pres and COO | 61 | $3,606,199 | |
John F. Rex (59) Exec. VP and CFO | 59 | $3,596,777 | |
Sir Andrew Philip Witty (56) CEO and Director | 56 | $2,156,946 | |
Richard Burke (76) Lead Independent Director since 2017 | 76 | 2017 | $433,401 |
Glenn Renwick (65) Independent Director since 2008 | 65 | 2008 | $379,278 |
William Ballard (78) Independent Director since 1993 | 78 | 1993 | $368,828 |
Gail Wilensky (76) Independent Director since 1993 | 76 | 1993 | $368,275 |
Michele Hooper (68) Independent Director since 2007 | 68 | 2007 | $365,900 |
Timothy Flynn (63) Independent Director since 2017 | 63 | 2017 | $353,172 |
Valerie Montgomery Rice (57) Independent Director since 2017 | 57 | 2017 | $346,716 |
F. William McNabb (62) Independent Director since 2018 | 62 | 2018 | $330,325 |
John Noseworthy (69) Independent Director since 2019 | 69 | 2019 | $221,294 |
Frances Jacobs | 2013 | ||
Thomas Roos (46) Senior Vice President and Chief Accounting Officer since 2015 | 46 | 2015 | |
Terry M. Clark | |||
James T. Barry Jr. (75) Director of Sales for Western Pennsylvania | 75 | ||
Jennifer Mound Smoter | |||
Dannette L. Smith | |||
Philip G.J. McKoy (48) Chief Information Officer | 48 | ||
Thomas Edward Roos (48) Sr. VP and Chief Accounting Officer | 48 |
UnitedHealth Group Incorporated is a for-profit American multinational managed healthcare and insurance company based in Minnetonka, Minnesota.
- Health Care > Managed Health Care
- Unitedhealth Group Inc, UnitedHealth Group Center, Minnetonka 55343, United States
- 952-936-1300
- Investor relations
Dividends
Ex-dividend date | N/A | Frequency | Quarterly | Annual dividend | +13.91% |
---|---|---|---|---|---|
Next dividend | N/A | Dividend yield | 1.58% | Growth period | 24 years |
Last dividend date | Yield 3 years | 1.39% | Growth 3 years | +14.71% | |
Last dividend | Yield 5 years | 1.33% | Growth 5 years | +16.14% |
Quarterly EPS estimates
Profit margin
Debt to assets
Cash flow
Balance sheet
(in millions USD) | 31 Mar 2024 | 31 Dec 2023 | |||
---|---|---|---|---|---|
Current assets | |||||
Cash | $28,414 | $25,427 | |||
Short term investments | $7,915 | $7,956 | |||
Net receivables | $46,481 | $38,970 | |||
Inventory | |||||
Total current assets | $88,942 | $78,437 | |||
Long term investments | $45,928 | $47,609 | |||
Property, plant & equipment | $10,429 | $11,450 | |||
Goodwill & intangible assets | $121,207 | $118,926 | |||
Total noncurrent assets | $195,268 | $195,283 | |||
Total investments | $53,843 | $55,565 | |||
Total assets | $284,210 | $273,720 | |||
Current liabilities | |||||
Accounts payable | $64,770 | $64,353 | |||
Deferred revenue | $3,206 | $3,355 | |||
Short long term debt | $9,787 | $4,274 | |||
Total current liabilities | $104,431 | $99,054 | |||
Long term debt | $63,850 | $58,263 | |||
Total noncurrent liabilities | $82,861 | $75,747 | |||
Total debt | $73,637 | $62,537 | |||
Total liabilities | $187,292 | $174,801 | |||
Stockholders' equity | |||||
Retained earnings | $90,118 | $95,774 | |||
Other stockholder equity | -$3,439 | -$7,027 | |||
Total stockholder equity | $86,688 | $88,756 |
(in millions USD) | 2023 | 2022 | ||
---|---|---|---|---|
Current assets | ||||
Cash | $25,427 | $23,365 | ||
Short term investments | $7,956 | $8,633 | ||
Net receivables | $38,970 | $30,450 | ||
Inventory | ||||
Total current assets | $78,437 | $69,069 | ||
Long term investments | $47,609 | $43,728 | ||
Property, plant & equipment | $11,450 | $10,128 | ||
Goodwill & intangible assets | $118,926 | $107,753 | ||
Total noncurrent assets | $195,283 | $176,636 | ||
Total investments | $55,565 | $52,361 | ||
Total assets | $273,720 | $245,705 | ||
Current liabilities | ||||
Accounts payable | $64,353 | $56,771 | ||
Deferred revenue | $3,355 | $3,075 | ||
Short long term debt | $4,274 | $3,110 | ||
Total current liabilities | $99,054 | $89,237 | ||
Long term debt | $58,263 | $54,513 | ||
Total noncurrent liabilities | $75,747 | $70,121 | ||
Total debt | $62,537 | $57,623 | ||
Total liabilities | $174,801 | $159,358 | ||
Stockholders' equity | ||||
Retained earnings | $95,774 | $86,156 | ||
Other stockholder equity | -$7,027 | -$8,393 | ||
Total stockholder equity | $88,756 | $77,772 |
Income statement
(in millions USD) | 31 Mar 2024 | 31 Dec 2023 | |||
---|---|---|---|---|---|
Revenue | |||||
Total revenue | $99,796 | $94,427 | |||
Cost of revenue | $76,791 | $72,425 | |||
Gross profit | $23,005 | $22,002 | |||
Operating activities | |||||
Research & development | |||||
Selling, general & administrative | $14,077 | $13,339 | |||
Total operating expenses | $15,074 | $14,313 | |||
Operating income | $7,931 | $7,689 | |||
Income from continuing operations | |||||
EBIT | $657 | $7,469 | |||
Income tax expense | $1,222 | $1,184 | |||
Interest expense | $844 | $830 | |||
Net income | |||||
Net income | -$1,409 | $5,455 | |||
Income (for common shares) | -$1,409 | $5,455 |
(in millions USD) | 2023 | 2022 | ||
---|---|---|---|---|
Revenue | ||||
Total revenue | $371,622 | $324,162 | ||
Cost of revenue | $280,664 | $244,545 | ||
Gross profit | $90,958 | $79,617 | ||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $54,628 | $47,782 | ||
Total operating expenses | $58,600 | $51,182 | ||
Operating income | $32,358 | $28,435 | ||
Income from continuing operations | ||||
EBIT | $31,595 | $27,916 | ||
Income tax expense | $5,968 | $5,704 | ||
Interest expense | $3,246 | $2,092 | ||
Net income | ||||
Net income | $22,381 | $20,120 | ||
Income (for common shares) | $22,381 | $20,120 |
Cash flows
(in millions USD) | 31 Mar 2024 | 31 Dec 2023 | |||
---|---|---|---|---|---|
Net income | -$1,409 | $5,455 | |||
Operating activities | |||||
Depreciation | $997 | $974 | |||
Business acquisitions & disposals | -$3,006 | -$1,062 | |||
Stock-based compensation | $372 | $208 | |||
Total cash flows from operations | $1,144 | -$5,193 | |||
Investing activities | |||||
Capital expenditures | -$743 | -$959 | |||
Investments | $492 | $1,073 | |||
Total cash flows from investing | -$6,340 | -$1,187 | |||
Financing activities | |||||
Dividends paid | -$1,729 | -$1,738 | |||
Sale and purchase of stock | -$2,586 | -$1,186 | |||
Net borrowings | $11,364 | -$1,568 | |||
Total cash flows from financing | $8,231 | -$7,156 | |||
Effect of exchange rate | -$48 | $48 | |||
Change in cash and equivalents | $2,987 | -$13,488 |
(in millions USD) | 2023 | 2022 | ||
---|---|---|---|---|
Net income | $22,381 | $20,120 | ||
Operating activities | ||||
Depreciation | $3,972 | $3,400 | ||
Business acquisitions & disposals | -$9,451 | -$18,044 | ||
Stock-based compensation | $1,059 | $925 | ||
Total cash flows from operations | $29,068 | $26,206 | ||
Investing activities | ||||
Capital expenditures | -$3,386 | -$2,802 | ||
Investments | -$1,777 | -$6,837 | ||
Total cash flows from investing | -$15,574 | -$28,476 | ||
Financing activities | ||||
Dividends paid | -$6,761 | -$5,991 | ||
Sale and purchase of stock | -$6,647 | -$5,747 | ||
Net borrowings | $4,280 | $12,536 | ||
Total cash flows from financing | -$11,529 | $4,226 | ||
Effect of exchange rate | $97 | $34 | ||
Change in cash and equivalents | $2,062 | $1,990 |
Recent institutional transactions
Quarter | Shareholder | Change |
Shares owned
Shares
|
Value (in thousands USD) |
---|---|---|---|---|
2024 Q2 | Dnb Asset Management As |
+18.37%
|
249,698 | $127,161,203 |
2024 Q2 | Beach Investment Counsel Inc/pa |
-98.43%
|
300 | $153 |
2024 Q2 | Jackson Wealth Management |
-95.90%
|
649 | $331,000 |
2024 Q2 | Douglas Lane & Associates |
+16.29%
|
83,597 | $42,572,395 |
2024 Q2 | Gamma Investing |
+92.24%
|
10,206 | $5,197,508 |
2024 Q2 | Neville Rodie & Shaw Inc |
-12.76%
|
27,711 | $14,112 |
2024 Q2 | Thurston, Springer, Miller, Herd & Titak, Inc |
Opened
|
3,065 | $1,560,823 |
2024 Q2 | Beese Fulmer Investment Management, Inc |
+9.01%
|
22,481 | $11,448,681 |
2024 Q2 | Modus Advisors |
+87.03%
|
2,364 | $1,204,076 |
2024 Q2 | Transcend Capital Advisors |
+10.23%
|
10,212 | $5,200,678 |
Institutional shareholders
Shareholder | Stake |
Shares owned
Shares
|
Value (in thousands USD) |
---|---|---|---|
Metatron Capital Sicav PLC | 102.33% | 941,851,250 | |
Vanguard Group Inc | 9.08% | 83,610,224 | |
Blackrock | 8.00% | 73,670,533 | |
State Street Corp | 4.97% | 45,699,253 | |
Fmr | 3.88% | 35,668,357 | |
Capital World Investors | 3.08% | 28,321,829 | |
Price T Rowe Associates Inc md/ | 2.83% | 26,062,928 | |
Wellington Management Group LL.P. | 2.64% | 24,283,224 | |
Jpmorgan Chase & Co | 2.59% | 23,840,608 | |
Morgan Stanley | 2.19% | 20,189,832 |